3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2026
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Several genomics and synthetic biology stocks are being highlighted as promising investments, with companies such as CRISPR Therapeutics and Beam Therapeutics mentioned. The time frame for this investment opportunity is unclear, with some reports referencing 2025 and others 2026. These stocks are being suggested as potential additions to investment portfolios.
Full coverage
1
ChartMill·6d ago2
Yahoo Finance·Apr 133ChartMill·Jun 304Yahoo Finance·Sep 185ChartMill·Jul 26Yahoo Finance·Jul 307
Zacks Investment Research·Jan 288Yahoo Finance·May 21